Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sensus Healthcare, Inc.SRTS · Entity 7142 | CHIEF OPERATING OFFICER | January 03, 2023 | April 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sensus Healthcare, Inc.
Report date January 03, 2023 · Filed April 22, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,754 |
Reported balance
Holding disclosure · report date 2023-01-03 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 12,754 F1: On January 11, 2023, the reporting person filed a Form 3 which inadvertently reported that the reporting person owned 18,000 shares of the issuer's common stock (including shares of restricted stock). In fact, the reporting person held 12,754 shares of the issuer's common stock (including shares of restricted stock) as of January 3, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: On January 11, 2023, the reporting person filed a Form 3 which inadvertently reported that the reporting person owned 18,000 shares of the issuer's common stock (including shares of restricted stock). In fact, the reporting person held 12,754 shares of the issuer's common stock (including shares of restricted stock) as of January 3, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2023 Filed Dec 20, 2023 18:29 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | Tax withholdingCommon Stock | 741 | $2.66 | $1,971.06 |
DisclosureSEC source: 0001415889-23-016774 · form4-12202023_061226.xml · nonDerivative · entry 1 Martinez Magdalena · CIK 0001960987 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,759 F1 · shares: Represents shares withheld to pay reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Read SEC document |
| December 19, 2023 Filed Apr 22, 2026 20:13 UTC Amendment | Sensus Healthcare, Inc. SRTS · Entity 7142 | Tax withholdingCommon Stock | 741 | $2.66 | $1,971.06 |
DisclosureSEC source: 0001960987-26-000004 · form4a-04222026_080428.xml · nonDerivative · entry 1 Martinez Magdalena · CIK 0001960987 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,013 F1 · shares: Represents shares withheld to pay reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. F2 · balance_after: On December 20, 2023, the reporting person filed a Form 4 which inadvertently reported that the reporting person owned 9,759 shares of the issuer's common stock as of December 19, 2023. In fact, the reporting person held 12,013 shares of the issuer's common stock (including 7,500 shares of restricted stock) as of December 19, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.